Khalsa Sahib S, Portnoff Larissa C, McCurdy-McKinnon Danyale, Feusner Jamie D
Laureate Institute for Brain Research, 6655 S Yale Ave, Tulsa, OK 74136 USA.
Oxley College of Health Sciences, The University of Tulsa, 1215 South Boulder Ave W, Tulsa, OK 74119 USA.
J Eat Disord. 2017 Jun 14;5:20. doi: 10.1186/s40337-017-0145-3. eCollection 2017.
Relapse after treatment for anorexia nervosa (AN) is a significant clinical problem. Given the level of chronicity, morbidity, and mortality experienced by this population, it is imperative to understand the driving forces behind apparently high relapse rates. However, there is a lack of consensus in the field on an operational definition of relapse, which hinders precise and reliable estimates of the severity of this issue. The primary goal of this paper was to review prior studies of AN addressing definitions of relapse, as well as relapse rates.
Data sources included PubMed and PsychINFO through March 19th, 2016. A systematic review was performed following the PRISMA guidelines. A total of ( = 27) peer-reviewed English language studies addressing relapse, remission, and recovery in AN were included.
Definitions of relapse in AN as well as definitions of remission or recovery, on which relapse is predicated, varied substantially in the literature. Reported relapse rates ranged between 9 and 52%, and tended to increase with increasing duration of follow-up. There was consensus that risk for relapse in persons with AN is especially high within the first year following treatment.
Standardized definitions of relapse, as well as remission and recovery, are needed in AN to accelerate clinical and research progress. This should improve the ability of future longitudinal studies to identify clinical, demographic, and biological characteristics in AN that predict relapse versus resilience, and to comparatively evaluate relapse prevention strategies. We propose standardized criteria for relapse, remission, and recovery, for further consideration.
神经性厌食症(AN)治疗后的复发是一个重大的临床问题。鉴于该人群所经历的慢性病程、发病率和死亡率水平,了解明显高复发率背后的驱动因素至关重要。然而,该领域对于复发的操作性定义缺乏共识,这阻碍了对这一问题严重程度进行精确且可靠的评估。本文的主要目的是回顾先前关于AN复发定义以及复发率的研究。
数据来源包括截至2016年3月19日的PubMed和PsychINFO。按照PRISMA指南进行系统综述。总共纳入了(=27)项关于AN复发、缓解和康复的同行评审英文研究。
AN中复发的定义以及作为复发前提的缓解或康复的定义在文献中差异很大。报告的复发率在9%至52%之间,并且往往随着随访时间的延长而增加。人们一致认为,AN患者在治疗后的第一年内复发风险特别高。
AN需要复发以及缓解和康复的标准化定义,以加速临床和研究进展。这应能提高未来纵向研究识别AN中预测复发与恢复力的临床、人口统计学和生物学特征的能力,并能比较评估复发预防策略。我们提出复发、缓解和康复的标准化标准以供进一步考虑。